Literature DB >> 15044432

5alpha-reduced glucocorticoids, novel endogenous activators of the glucocorticoid receptor.

Kerry J McInnes1, Christopher J Kenyon, Karen E Chapman, Dawn E W Livingstone, Linsay J Macdonald, Brian R Walker, Ruth Andrew.   

Abstract

Metabolism of glucocorticoids to A-ring-reduced dihydro- and tetrahydro-derivatives by means of hepatic 5alpha- and 5beta-reductases has long been regarded as a pathway of irreversible inactivation. However, 5alpha-reduced metabolites of other steroids, e.g. testosterone and aldosterone, have significant biological activity. We investigated whether 5alpha-reduced metabolites of corticosterone are glucocorticoid receptor (GR) agonists. Corticosterone, 5alpha-tetrahydrocorticosterone (5alphaTHB), and 5alpha-dihydrocorticosterone (5alphaDHB) were similarly effective in displacing tritiated dexamethasone from binding sites in hepatocytes, whereas 5beta-reduced metabolites were less effective in binding. 5alphaTHB had glucocorticoid receptor agonist effects in vitro and in vivo. After transient co-transfection of hGR and a murine mammary tumor virus-luciferase reporter into HeLa cells, 5alphaTHB was active to a comparable extent as corticosterone (28-fold versus 37-fold induction, respectively, at 1 microm) and additive to the effect of corticosterone. 5beta-Reduced metabolites did not activate GR. In H4IIE hepatoma cells, both 5alphaTHB and corticosterone induced mRNA expression of tyrosine aminotransferase and phosphoenolpyruvate carboxykinase (6.0-versus 10.1-fold and 3.5-versus 3.9-fold at 1 microM, respectively), an effect that was inhibited by RU486. To assess in vivo glucocorticoid activity, suppression of plasma ACTH was demonstrated in adrenalectomized rats after intraperitoneal administration of vehicle (ACTH trough 80.2 pm), corticosterone (5 mg/kg; 22 pm, p < 0.001) or 5alphaTHB (5 mg/kg; 51.3 pm, p < 0.005). Similar endogenous concentrations of corticosterone and 5alphaTHB were detected in rat liver homogenates by gas chromatography mass spectrometry. We conclude that 5alpha-reduced glucocorticoids bind to and activate GR. Transcription of glucocorticoid-regulated genes in tissues that express 5alpha-reductases will thus be influenced by intracellular levels of both corticosterone and its 5alpha-reduced metabolites.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15044432     DOI: 10.1074/jbc.M402822200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Microarray and real-time PCR analysis of adrenal gland gene expression in the 7-day-old rat: effects of hypoxia from birth.

Authors:  Eric D Bruder; Julie J Lee; Eric P Widmaier; Hershel Raff
Journal:  Physiol Genomics       Date:  2007-01-09       Impact factor: 3.107

2.  Glucocorticoid signaling and lipid metabolism disturbances in the liver of rats treated with 5α-dihydrotestosterone in an animal model of polycystic ovary syndrome.

Authors:  Danijela Vojnović Milutinović; Ana Teofilović; Nataša Veličković; Jelena Brkljačić; Sanja Jelača; Ana Djordjevic; Djuro Macut
Journal:  Endocrine       Date:  2021-01-15       Impact factor: 3.633

3.  Prenatal corticosteroid exposure alters early developmental seizures and behavior.

Authors:  Libor Velíšek
Journal:  Epilepsy Res       Date:  2011-03-22       Impact factor: 3.045

4.  Substrate specificity and inhibitor analyses of human steroid 5β-reductase (AKR1D1).

Authors:  Mo Chen; Jason E Drury; Trevor M Penning
Journal:  Steroids       Date:  2011-01-19       Impact factor: 2.668

5.  5α-reduced glucocorticoids exhibit dissociated anti-inflammatory and metabolic effects.

Authors:  C Yang; M Nixon; C J Kenyon; D E W Livingstone; R Duffin; A G Rossi; B R Walker; R Andrew
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

Review 6.  Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease.

Authors:  Patrick W F Hadoke; Javaid Iqbal; Brian R Walker
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

Review 7.  Non-genomic effect of glucocorticoids on cardiovascular system.

Authors:  Sung Ryul Lee; Hyoung Kyu Kim; Jae Boum Youm; Louise Anne Dizon; In Sung Song; Seung Hun Jeong; Dae Yun Seo; Kyoung Soo Ko; Byoung Doo Rhee; Nari Kim; Jin Han
Journal:  Pflugers Arch       Date:  2012-09-23       Impact factor: 3.657

Review 8.  5β-Reduced steroids and human Δ(4)-3-ketosteroid 5β-reductase (AKR1D1).

Authors:  Mo Chen; Trevor M Penning
Journal:  Steroids       Date:  2014-02-08       Impact factor: 2.668

9.  Sex dependent influence of a functional polymorphism in steroid 5-α-reductase type 2 (SRD5A2) on post-traumatic stress symptoms.

Authors:  Charles F Gillespie; Lynn M Almli; Alicia K Smith; Bekh Bradley; Kimberly Kerley; Daniel F Crain; Kristina B Mercer; Tamara Weiss; Justine Phifer; Yilang Tang; Joseph F Cubells; Elisabeth B Binder; Karen N Conneely; Kerry J Ressler
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-03-15       Impact factor: 3.568

10.  Temperament type specific metabolite profiles of the prefrontal cortex and serum in cattle.

Authors:  Bodo Brand; Frieder Hadlich; Bettina Brandt; Nicolas Schauer; Katharina L Graunke; Jan Langbein; Dirk Repsilber; Siriluk Ponsuksili; Manfred Schwerin
Journal:  PLoS One       Date:  2015-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.